Kottayil George
SEC insider (Form 3/4/5 filer). CIK 0001895357. Director at Grace Therapeutics, Inc. (GRCE). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 17, 2026. Located in PRINCETON, NJ.
Companies Kottayil George has filed insider reports for
- Grace Therapeutics, Inc. (GRCE): Director
Kottayil George
CIK: 0001895357
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GRCE
Grace Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 17, 2026GRCE
Grace Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
12.2K shares- - Jan 8, 2026GRCE
Grace Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
10K shares- - May 9, 2025GRCE
Grace Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
10K shares-
1-3 of 3 transactions